Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022-2031.

Dina Abushanab Clara Marquina Jedidiah I Morton Daoud Al-Badriyeh Melanie A Lloyd Dianna J Magliano Danny Liew Zanfina Ademi

Published in: PharmacoEconomics (2023)

CVD in people with type 2 diabetes will substantially impact the Australian healthcare system and society over the next decade. Future work to investigate different strategies to optimize the control of risk factors for the prevention and treatment of CVD in type 2 diabetes in Australia is warranted.

Keyphrases

cardiovascular disease
type diabetes
public health
healthcare
mental health
glycemic control
current status
insulin resistance
coronary artery disease
cardiovascular risk factors
risk assessment
health promotion
smoking cessation